0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PCR and NGS-Based Molecular Diagnostics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-24D8237
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PCR and NGS Based Molecular Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Global PCR and NGS-Based Molecular Diagnostics Market Insights, Forecast to 2030

Code: QYRE-Auto-24D8237
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PCR and NGS-Based Molecular Diagnostics Market

Market Analysis and Insights: Global PCR and NGS-Based Molecular Diagnostics Market
The global PCR and NGS-Based Molecular Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of PCR and NGS-Based Molecular Diagnostics include Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, Bioo Scientific, Agilent, Pillar Biosciences and LC-Bio Technologies (Hangzhou) CO. LTD., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
PCR and NGS-Based Molecular Diagnostics is widely used in various fields, such as Hospitals, Academics/Research Institutions and Others,, etc. Hospitals provides greatest supports to the PCR and NGS-Based Molecular Diagnostics industry development. In 2023, global % revenue of PCR and NGS-Based Molecular Diagnostics went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for PCR and NGS-Based Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of PCR and NGS-Based Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for PCR and NGS-Based Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the PCR and NGS-Based Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global PCR and NGS-Based Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PCR and NGS-Based Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of PCR and NGS-Based Molecular Diagnostics Market Report

Report Metric Details
Report Name PCR and NGS-Based Molecular Diagnostics Market
Segment by Type
Segment by Application
  • Hospitals
  • Academics/Research Institutions
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, Bioo Scientific, Agilent, Pillar Biosciences, LC-Bio Technologies (Hangzhou) CO. LTD., iGen Technologies, Burning Rock
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of PCR and NGS-Based Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PCR and NGS-Based Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PCR and NGS-Based Molecular Diagnostics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the PCR and NGS-Based Molecular Diagnostics Market report?

Ans: The main players in the PCR and NGS-Based Molecular Diagnostics Market are Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, Bioo Scientific, Agilent, Pillar Biosciences, LC-Bio Technologies (Hangzhou) CO. LTD., iGen Technologies, Burning Rock

What are the Application segmentation covered in the PCR and NGS-Based Molecular Diagnostics Market report?

Ans: The Applications covered in the PCR and NGS-Based Molecular Diagnostics Market report are Hospitals, Academics/Research Institutions, Others

What are the Type segmentation covered in the PCR and NGS-Based Molecular Diagnostics Market report?

Ans: The Types covered in the PCR and NGS-Based Molecular Diagnostics Market report are Biomarker Discovery, Blood Sample Testig, Others

Recommended Reports

Cancer Molecular Diagnostics

PCR Market & Equipment

Molecular Diagnostic Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2019-2030)
2.2 Global PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue PCR and NGS-Based Molecular Diagnostics by Players
3.1.1 Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of PCR and NGS-Based Molecular Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2023
3.5 Global Key Players of PCR and NGS-Based Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of PCR and NGS-Based Molecular Diagnostics, Product and Application
3.7 Global Key Players of PCR and NGS-Based Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2019-2030)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type
6.2.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
6.2.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030)
6.2.3 North America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application
6.3.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
6.3.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030)
6.3.3 North America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country
6.4.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024)
6.4.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2019-2030)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type
7.2.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application
7.3.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country
7.4.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China PCR and NGS-Based Molecular Diagnostics Market Size (2019-2030)
8.2 China PCR and NGS-Based Molecular Diagnostics Market Size by Type
8.2.1 China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
8.2.2 China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030)
8.2.3 China PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
8.3 China PCR and NGS-Based Molecular Diagnostics Market Size by Application
8.3.1 China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
8.3.2 China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030)
8.3.3 China PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia PCR and NGS-Based Molecular Diagnostics Market Size (2019-2030)
9.2 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type
9.2.1 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
9.3 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application
9.3.1 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
9.4 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region
9.4.1 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Details
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.1.5 Thermofisher Recent Developments
11.2 Illumine
11.2.1 Illumine Company Details
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.2.5 Illumine Recent Developments
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Details
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.3.5 Paragon Genomics Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.5.5 Qiagen Recent Developments
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Details
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.6.5 Bioo Scientific Recent Developments
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.7.5 Agilent Recent Developments
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Details
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.8.5 Pillar Biosciences Recent Developments
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Developments
11.10 iGen Technologies
11.10.1 iGen Technologies Company Details
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.10.5 iGen Technologies Recent Developments
11.11 Burning Rock
11.11.1 Burning Rock Company Details
11.11.2 Burning Rock Business Overview
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
11.11.5 Burning Rock Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Biomarker Discovery
    Table 3. Key Players of Blood Sample Testig
    Table 4. Key Players of Others
    Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2019-2024)
    Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2025-2030)
    Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
    Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
    Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
    Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
    Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Players (2019-2024)
    Table 17. Global Top PCR and NGS-Based Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2023)
    Table 18. Global PCR and NGS-Based Molecular Diagnostics Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Headquarters and Area Served
    Table 21. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Product and Application
    Table 22. Global Key Players of PCR and NGS-Based Molecular Diagnostics, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2019-2024)
    Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2025-2030)
    Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Application (2019-2024)
    Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Application (2025-2030)
    Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America PCR and NGS-Based Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe PCR and NGS-Based Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia PCR and NGS-Based Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia PCR and NGS-Based Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Thermofisher Company Details
    Table 65. Thermofisher Business Overview
    Table 66. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
    Table 67. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 68. Thermofisher Recent Developments
    Table 69. Illumine Company Details
    Table 70. Illumine Business Overview
    Table 71. Illumine PCR and NGS-Based Molecular Diagnostics Product
    Table 72. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 73. Illumine Recent Developments
    Table 74. Paragon Genomics Company Details
    Table 75. Paragon Genomics Business Overview
    Table 76. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
    Table 77. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 78. Paragon Genomics Recent Developments
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche PCR and NGS-Based Molecular Diagnostics Product
    Table 82. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 83. Roche Recent Developments
    Table 84. Qiagen Company Details
    Table 85. Qiagen Business Overview
    Table 86. Qiagen PCR and NGS-Based Molecular Diagnostics Product
    Table 87. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 88. Qiagen Recent Developments
    Table 89. Bioo Scientific Company Details
    Table 90. Bioo Scientific Business Overview
    Table 91. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
    Table 92. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 93. Bioo Scientific Recent Developments
    Table 94. Agilent Company Details
    Table 95. Agilent Business Overview
    Table 96. Agilent PCR and NGS-Based Molecular Diagnostics Product
    Table 97. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 98. Agilent Recent Developments
    Table 99. Pillar Biosciences Company Details
    Table 100. Pillar Biosciences Business Overview
    Table 101. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product
    Table 102. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 103. Pillar Biosciences Recent Developments
    Table 104. LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
    Table 105. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
    Table 106. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
    Table 107. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 108. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Developments
    Table 109. iGen Technologies Company Details
    Table 110. iGen Technologies Business Overview
    Table 111. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
    Table 112. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 113. iGen Technologies Recent Developments
    Table 114. Burning Rock Company Details
    Table 115. Burning Rock Business Overview
    Table 116. Burning Rock PCR and NGS-Based Molecular Diagnostics Product
    Table 117. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 118. Burning Rock Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Biomarker Discovery Features
    Figure 4. Blood Sample Testig Features
    Figure 5. Others Features
    Figure 6. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Academics/Research Institutions Case Studies
    Figure 10. Others Case Studies
    Figure 11. PCR and NGS-Based Molecular Diagnostics Report Years Considered
    Figure 12. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region: 2023 VS 2030
    Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2023
    Figure 16. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2023
    Figure 18. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
    Figure 20. North America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
    Figure 21. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 22. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
    Figure 26. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
    Figure 27. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 28. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China PCR and NGS-Based Molecular Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
    Figure 36. China PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
    Figure 37. Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
    Figure 39. Asia PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
    Figure 40. Asia PCR and NGS-Based Molecular Diagnostics Market Share by Region (2019-2030)
    Figure 41. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 51. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 58. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 59. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 60. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 61. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 62. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 63. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 64. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 65. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 66. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 67. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners